2024 Q2 Form 10-Q Financial Statement

#000164033424000720 Filed on May 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.05K $16.90K
YoY Change 35.2%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $10.05K $16.90K
YoY Change -12.99% 35.2%
Operating Profit
YoY Change
Interest Expense $9.043K $9.042K
YoY Change 0.0% 1.11%
% of Operating Profit
Other Income/Expense, Net -$9.043K -$9.042K
YoY Change 0.0% 1.11%
Pretax Income -$19.09K -$25.94K
YoY Change 20.99%
Income Tax
% Of Pretax Income
Net Earnings -$19.09K -$25.94K
YoY Change -7.28% 20.98%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 27.82M shares 27.82M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00
Total Long-Term Assets $0.00 $0.00
Total Assets $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $58.21K
YoY Change 5.41%
Accrued Expenses $113.3K $109.7K
YoY Change 15.25%
Deferred Revenue
YoY Change
Short-Term Debt $156.3K
YoY Change 37.43%
Long-Term Debt Due $155.6K
YoY Change 0.0%
Total Short-Term Liabilities $615.6K $596.5K
YoY Change 15.03% 15.92%
LONG-TERM LIABILITIES
Long-Term Debt $67.33K
YoY Change 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $67.33K
YoY Change 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $615.6K $596.5K
Total Long-Term Liabilities $67.33K
Total Liabilities $682.9K $663.8K
YoY Change 13.35% 14.08%
SHAREHOLDERS EQUITY
Retained Earnings -$233.4M -$233.4M
YoY Change 0.03% 0.04%
Common Stock $237.9M $237.9M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$682.9K -$663.8K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$19.09K -$25.94K
YoY Change -7.28% 20.98%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$5.500K -$16.45K
YoY Change -2.89%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.500K $16.45K
YoY Change -2.89%
NET CHANGE
Cash From Operating Activities -5.500K -$16.45K
Cash From Investing Activities
Cash From Financing Activities 5.500K $16.45K
Net Change In Cash 0.000 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$5.500K -$16.45K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
12500 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
8943 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8943 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21443 usd
CY2023Q1 clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
CY2023Q1 clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
27819385 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-560442 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-25942 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21443 usd
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001619227
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27819385 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27819385 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27819385 shares
CY2024Q1 clow Due To Related Party Current
DueToRelatedPartyCurrent
162595 usd
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
333-199193
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Cloudweb, Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-0978297
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
800 W El Camino Real Suite 180
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Mountain View
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94040
CY2024Q1 dei City Area Code
CityAreaCode
650
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
963-7749
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27819385 shares
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
16900 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
9042 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9042 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-25942 usd
CY2024Q1 clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
CY2024Q1 clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
27819385 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-637860 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-663802 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21443 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-581885 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-25942 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
449 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4440 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
9043 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
8944 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16450 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16939 usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
16450 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
16939 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16450 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16939 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q4 clow Due To Related Party Current
DueToRelatedPartyCurrent
139809 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
55326667 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
55327097 shares
CY2024Q1 us-gaap Notes Payable
NotesPayable
69486 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
69486 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
2160 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2160 usd
CY2024Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
67326 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
67326 usd
CY2024Q1 clow Debt Instrument Accrued Interest
DebtInstrumentAccruedInterest
116690 usd
CY2023Q4 clow Debt Instrument Accrued Interest
DebtInstrumentAccruedInterest
11256 usd
CY2024Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
153482 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
153482 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
153482 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
153482 usd
CY2024Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
153482 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
109679 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
106070 usd
CY2022 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
2500000 shares
CY2022 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
2500 usd
CY2022Q4 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
2.10

Files In Submission

Name View Source Status
0001640334-24-000720-index-headers.html Edgar Link pending
0001640334-24-000720-index.html Edgar Link pending
0001640334-24-000720.txt Edgar Link pending
0001640334-24-000720-xbrl.zip Edgar Link pending
clow-20240331.xsd Edgar Link pending
clow_10q.htm Edgar Link pending
clow_ex311.htm Edgar Link pending
clow_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
clow-20240331_cal.xml Edgar Link unprocessable
clow-20240331_def.xml Edgar Link unprocessable
clow-20240331_lab.xml Edgar Link unprocessable
clow-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clow_10q_htm.xml Edgar Link completed